AzTrials
AzTrials

ObesityOSVNCT02326480

Genetic Analysis of Childhood Obesity

An observational study of Obesity, run by Lille Catholic University at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Identify news genetic causes of different type of obesity (syndromic, familial or isolated obesity) by highlighting new mutations or new implied genes Read more about this study

Who is it for?
Ages 6 months to 18 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
Identification of genetic causes of obesity
How many people
300 participants
Where
1 siteFrance
Study dates
Jan 2015to Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Three categories of obese children with their biological parents will be included (syndromic, familial, isolated obesity).

Who may be able to join

  • BMI > curve of IOTF 30 (International Obesity Task Force)
  • Age: between 6 months old and 18 years old
  • Child presenting syndromic, isolated or familial obesity.

Who cannot join

  • Common obesity
  • Impossibility for blood sampling
  • Impossibility to receive information
  • Participation refusal of one of the parents
  • Refusal to sign the informed consent
  • Neither Healthcare coverage nor insurance

Trial locations and contacts

1 site in 1 country.

Amélie Lansiaux, MD, PhD contact

lansiaux.amelie@ghicl.net

Mélanie Hamez contact

hamez.melanie@ghicl.net

France1 site, 1 recruiting
  • Hôpital Saint Vincent de Paul

    Lille

    Louise Montagne

    Recruiting

Other trials in France

About this study

Identify news genetic causes of different type of obesity (syndromic, familial or isolated obesity) by highlighting new mutations or new implied genes

Conditions
Obesity
Being tested
Identification of genetic causes of obesity
Keywords
Childhood Obesity, Genetics
Medical subject headings
Obesity, Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Identification of genetic causes of obesityOther

    A blood test will be performed to the child and his/her parents with the aim of identifying genetic causes of obesity. Different analysis will be as follows: caryotypes, Raindance, whole exome, in order to find potential mutations or new genes associated to this condition

Study groups in NCT02326480
Study groupRoleWhat they receive
Syndromic obesityIdentification of genetic causes of obesity
Familial obesityIdentification of genetic causes of obesity
Receives: Other: Identification of genetic causes of obesity
Isolated obesityIdentification of genetic causes of obesity
Receives: Other: Identification of genetic causes of obesity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To identify the number of mutations or genes involved in genetic causes of Child obesity

    Children with obesity and their parents will be recruited to establish genetic causes of obesity. This will allow perform genetic analysis using new approaches for the identification of involved mutations or new candidate genes

    Measured: first day of enrollement

Secondary outcomes (3)
  1. To identify the number of mutations in the population

    Measured: first day of enrollement

  2. To identify the number of new mutations present in the children's DNA and absent from their parents' genomes

    This approach will allow the identification of specific mutations that are present only in affected children but not in their parents

    Measured: first day of enrollement

  3. To determine number of phenotypes associated to the child obesity genotype

    Measured: first day of enrollement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2014 (estimated)
  2. Study startJan 2015
  3. Primary completionDec 2020 (estimated)
  4. Study completionJun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02326480
Sponsor's protocol ID
RC-P0036
Acronym
OSV
Status last verified
Mar 2020
First submitted
15 Dec 2014
Last updated
3 Mar 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Amélie Lansiaux, MD, PhD (lansiaux.amelie@ghicl.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To identify the number of mutations or genes involved in genetic causes of Child obesity (time frame: first day of enrollement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in